MGTX

Insider trade Sale by Forbes Alexandria (PRESIDENT & CEO)

13d ago

News MeiraGTx Sales Jump 1,133 Percent

14d ago

SEC filing MGTX Announces $25M bota-vec Acquisition, FDA Breakthrough for AAV2-hAQP1

19d ago

Insider trade Sale by Richard Giroux (CFO & COO)

38d ago

SEC filing MGTX Announces $200M Upfront Payment, $105M Hologen Investment, 70% Hologen Stake in HNAI, Neuro Framework Amendment, Manufacturing Deal Expansion

39d ago

Insider trade Sale by Richard Giroux (CFO & COO)

41d ago

SEC filing MGTX Priced $9.00 Offering, 11.1M Shares, $93.3M Net Proceeds, Funds 2028 Launches

46d ago

News MeiraGTx eyes $100M equity offering after gene therapy deal with J&J

46d ago

News Eli Lilly Partner MeiraGTx Regains Rights For Genetic Eye Disease Drug From Johnson & Johnson

47d ago

News MeiraGTx Announces the Acquisition of Botaretigene Sparoparvovec (bota-vec) for the Treatment of X-linked Retinitis Pigmentosa (XLRP)

47d ago

SEC filing MGTX Reports Positive 3-Year Data from AAV-hAQP1 Phase 1 AQUAx Study, XQ Improvements Maintained, UWSFR Increases Sustained, Safety Confirmed, Webcast Today 8:00 a.m. ET

47d ago

News MeiraGTx rises on upcoming Phase 1 readout for gene therapy

48d ago

Insider trade Sale by Stuart Naylor (CHIEF DEV. OFFICER)

55d ago

Insider trade Sale by Alexandria Forbes (PRESIDENT & CEO)

69d ago

Scanner Unusual volume (z=2.6)

169d ago

Scanner Unusual volume (z=2.6)

170d ago

Scanner Unusual volume (z=2.6)

171d ago